Modified glycopeptides

Details Modified glycopeptides Modified glycopeptides

1985-08-14

1987-02-17

Phillips, Delbert R.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

530322, A61K 3700, C07K 900

Patent

active

046439870

ABSTRACT:
Novel aracyl glycopeptide derivatives of formula 1 and methods for their preparation from the glycopeptide antibiotics vancomycin, A51568A, A51568B, M43A and M43D, are provided. The new glycopeptide derivatives are useful antibacterial agents.

REFERENCES:
patent: 3067099 (1962-12-01), McCormick et al.
patent: 4495179 (1985-01-01), Hoehn et al.
patent: 4497802 (1985-02-01), Debono
patent: 4547488 (1985-10-01), Merkel
patent: 4548925 (1985-10-01), Higgins, Jr. et al.
Harris et al., "Structure of the Glycopeptide Antibiotic Vancomycin. Evidence for an Asparagine Residue in the Peptide," J. Am. Chem. Soc. 104, 4293-4295 (1982).
Pfeiffer, "Structural Features of Vancomycin," Reviews of Infectious Diseases, vol. 3, Suppl., S205-S209 (Nov.-Dec. 1981).
Perkins, "Specificity of Combination Between Mucopeptide Precursors and Vancomycin or Ristocetin," Biochem. J. 111, 195-205 (1969).
Derwent Abstract No. 84-160164/26 (Eli Lilly and Company) of European Pat. No. 112-184-A (Jun. 27, 1984).

Affiliated with

Also associated with

Rating

Modified glycopeptides does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Modified glycopeptides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Modified glycopeptides will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1938526